This guidance has been produced by a multidisciplinary working party on behalf of the UK Chemotherapy Board which includes specialist representation from medical, dental and nursing teams across the UK.
These updated guidelines provide recommendations for the treatment of adults with spasticity with botulinum toxin as part of an overall patient management programme.